-
Study aim
-
To compare the effectiveness of the three methods: healing with dry amniotic dressing, dressing with platelet derived growth factor, and conventional surgical debridement on the improvement of diabetic foot ulcer
-
Design
-
This is a randomized clinical trial, phase II, in which 123 eligible patients will be randomly assigned to the intervention and control groups
-
Settings and conduct
-
The eligible patients with diabetic foot ulcer referring to the Imam Hussein Hospital in Tehran city during the study period will be enrolled in the trial and will be randomly assigned to the intervention and control groups through the block randomization.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria:
Age of 18 to 70 years,
Diabetic foot ulcer with dimension between 1 and 10 cm,
Level 1 or 2 based on Vegner scale,
HbA1c less than 8,
Suitable tissue circulation,
Exclusion criteria:
Pregnancy or breastfeeding,
Osteomyelitis,
Malnutrition,
Chemotherapy or radiotherapy,
Malignancy,
Autoimmune diseases,
Renal diseases needing dialysis,
Immunosuppressive drugs
-
Intervention groups
-
Intervention group 1:
Wound irrigation and then healing with dry amniotic dressing daily for 10 weeks
Intervention group 2:
Wound irrigation and then dressing with platelet-derived growth factor daily for 10 weeks
Control group:
Wound irrigation and then conventional surgical debridement daily for 10 weeks
-
Main outcome variables
-
Primary outcome:
Improve diabetic foot ulcers